RT @sanamloghavi@twitter.com

Final #hemepath 🧠 teaser of 2022… I’d love to hear #MDSsm experts ops. How would U classify?
Older lady w/ thrombocytopenia (47K) neutropenia (1.3K), normal Hgb
BM:Meg +erythroid dysplasia,15% ring sideroblasts (iron stain 👇🏻).
NGS shows an SF3B1 K700E with 4% VAF.

🐦🔗: https://twitter.com/sanamloghavi/status/1608844508426567685

RT @sanamloghavi@twitter.com

I  love cases that make me think.. Never a dull day at #hemepathMDA
Tune in: a #hemepath #MDSSM case for your learning pleasure.. Enjoy!
This is the bone marrow of an elderly woman (>65 yr) with marked pancytopenia and progressive transfusion dependency. 🧵 1/

🐦🔗: https://twitter.com/sanamloghavi/status/1606036887021314049

RT @CyclingDoctor@twitter.com

Today @ 3:30
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures

#ASH22 #mmsm #leusm #mdssm
@KellyLBolton@twitter.com

https://ash.confex.com/ash/2022/webprogram/Paper158992.html

🐦🔗: https://twitter.com/CyclingDoctor/status/1602308037552885761

RT @SamUrrutia_@twitter.com

At #ASH22? Can't decide what poster to see? Come visit at #3090 and learn about spliceosome mutations in #mdssm Get the poster below!

🐦🔗: https://twitter.com/SamUrrutia_/status/1602100234791829505

RT @Dr_AmerZeidan@twitter.com

With #MDSsm legend/giant & a true hero of mine with countless contributions to field at #ASH22 Dr John Bennett who continues to be active in academia & looks younger than ever. Dr Bennett was one of FAB classification founders & worked on defining #MDSsm before I was even born https://twitter.com/i/web/status/1601635723958185984

🐦🔗: https://twitter.com/Dr_AmerZeidan/status/1601635723958185984

RT @drsomedeb@twitter.com

If you treat #MDSsm & want to learn about classes/ subgroups that matter most in #WHO and #ICC 2022, stop by our presentation on analysis of @MoffittNews@twitter.com database Sunday AM #ASH22 Excited to represent @MDS_IC@twitter.com @ASH_hematology@twitter.com @Ramikomrokji@twitter.com @Dr_AmerZeidan@twitter.com @sanamloghavi@twitter.com @ZhuoerXie@twitter.com

🐦🔗: https://twitter.com/drsomedeb/status/1601224096330616832

RT @Anand_88_Patel@twitter.com

Today's #ASH22 Educational Session focus is the MDS session led by @beatalleukemia@twitter.com! #mdssm

- Risk stratification by Dr. Cazzola
- inflammation in lower-risk MDS @Amitvermamds@twitter.com
- new combination therapies @beatalleukemia@twitter.com

https://annualmeeting.hematology.org/live-stream/37816440/Novel-Approaches-in-MDS

🐦🔗: https://twitter.com/Anand_88_Patel/status/1600875095509065730

RT @sanamloghavi@twitter.com

en route with #MDSsm and #MPNsm royalty 👑….we all ended up in the same row by chance ✈️ #ASH22
Houston➡️ NOLA https://twitter.com/ash_hematology/status/1600856480026075136

🐦🔗: https://twitter.com/sanamloghavi/status/1600879262935957506

RT @sanamloghavi@twitter.com

Congrats to @SibaElHussein@twitter.com for her review on implications of clonal hierarchy on MDS phenotype just out in @Cancers_MDPI@twitter.com We hope you can find some time this holiday season to read it. https://www.mdpi.com/2072-6694/14/22/5690 #mdssm #leusm #hemepath

🐦🔗: https://twitter.com/sanamloghavi/status/1595513682905423872